Search Results 1451-1460 of 10304 for total t4

1. A Study of PROQOL (Patient Reported Outcome Quality of Life) Tool in the Hematology and Oncology Population - Mayo Clinic

   Ability to use the iPad to complete the tool, and answer a post tool survey. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

2. Clinical Trials - A Study of the BeWell360-CPR

   Willingness to provide informed consent and complete study activities. Without any cognitive impairment challenges; Ability to speak English language ...

3. A Study to Evaluate Adjuvant Ado-Trastuzumab Emtansine (T-DM1) in HER2 Positive Breast Cancer - Mayo Clinic

   Total bilirubin ≤1.5 x upper limit of normal (ULN). ... Locally advanced tumors at diagnosis (T4) ... total bilirubin, INR, PTT, and alkaline phosphatase on ...

4. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

   Total Bilirubin ≤ 1.5x Upper Limit of Normal (ULN) or ≤ 3x ULN for patients with documented Gilbert's syndrome; Aspartate aminotransferase (AST)/ alanine ...

5. A Study to Evaluate TAB006, as Monotherapy and in Combination with Toripalimab, in Patients with Previously Treated, Advanced Malignancies - Mayo Clinic

   Total bilirubin (TBIL) ≤ 1.5 times (x) the ULN ... The thyroid function test free triiodothyronine (FT3), free T4 ... complete hysterectomy) or ...

6. Cardiovascular Medicine - Clinical trials

   Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...

7. Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors - Mayo Clinic

   Total bilirubin ≤ 1.5 x ULN (in patients with liver metastases or known Gilbert's syndrome, total bilirubin must be ≤ 3.0 x ULN). Aspartate ...

8. A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma - Mayo Clinic

   - Part B: To evaluate the activity of SAR650984 (isatuximab) as assessed by overall response rate (ORR) in RRMM patients previously treated with daratumumab.

9. Clinical trials - Oncology (Medical)

   ... complete repository of specimens from patients with thoracic disease including but not limited to suspected lung cancer, mediastinal and pleural tumors and ...

10. Clinical trials - Oncology (Medical)

    Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis. Cerebrospinal Fluid Biomarkers for Brain Tumors. Rochester, Minn ...